5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety
Introduction
The brain γ-aminobutyric acid (GABA)-ergic system is the neurotransmitter system most strongly linked to anxiety. Since their introduction in the early 1960s, benzodiazepines are still the most widely prescribed compounds in the treatment of anxiety disorder. Over the years, other neurotransmitter systems have received much attention as potential targets in the search for new anxiolytics with fewer side effects. The serotonergic (5-HT) system is one of the neurotransmitter systems associated with anxiety (Griebel, 1995). Research has focussed especially on the 5-HT1A receptor subtype, but so far, this has resulted in only few clinically effective compounds. More recent is the interest in the neuropeptide corticotropin-releasing hormone (CRH). This neuropeptide is known to be a key modulator of behavioural, autonomic, and neuroendocrine responses to stress (Dunn and Berridge, 1990). Persistent changes in central nervous system CRH may underlie the development of mood and anxiety disorders (Heim and Nemeroff, 1999). However, lack of highly selective agonists and antagonists for both CRH receptor subtypes has hampered research into the role of CRH in anxiety. In the last decade, genetically altered mice have been generated to further study the role of neurotransmitter systems in fear and anxiety (for reviews, see Belzung, 2001, Holmes, 2001). By selective inactivation of specific genes, knockout mice can be created, whereas adding extra genes to the genome results in the overexpression of a specific gene product. In this way, the function of a specific gene can be investigated. In the present paper, behavioural and physiological findings obtained with 5-HT1A knockout (1AKO) mice and mice overexpressing CRH (CRH-OE) will be reviewed, and new data from our research group will be presented.
Section snippets
Serotonin and 5-HT1A receptors
The serotonergic neurotransmitter system has one endogenous ligand, 5-HT, but is rather complex because of the existence of at least 14 5-HT receptor subtypes (Hoyer et al., 1994). The 5-HT1A receptor has been well characterized pharmacologically, thanks to the availability of selective and potent agonists and antagonists. Both agonists and antagonists modulate anxiety behaviour in animals and, importantly, 5-HT1A receptor agonists also modulate anxiety in humans. The partial 5-HT1A receptor
CRH and anxiety
CRH is involved in regulating adaptive responses to stress. CRH not only activates the hypothalamic pituitary adrenal axis and the autonomic nervous system, but also modulates behavioural responses to a wide range of stressful stimuli. Central CRH administration has arousing effects, including increases in heart rate and blood pressure, and increases in locomotion and acoustic startle response (Koob et al., 1993). This profile of behavioural activation shifts to enhanced suppression of
Conclusions
The present review shows that reports on anxiety behaviour in 1AKO and CRH-OE mice are not conclusive. Some research groups observed enhanced anxiety behaviour in approach avoidance paradigms, but this could not always be replicated in other approach avoidance studies or in other laboratories. Anxiety tests modelling other aspects of anxiety, like stress-induced hyperthermia, which is independent of locomotor activity, and fear conditioning both yielded negative results in 1AKO mice as well as
References (88)
- et al.
Effects of repeated administration of corticotropin-releasing factor on schedule-controlled behavior in rats
Pharmacol. Biochem. Behav.
(1993) - et al.
Metallothionein gene expression and metal regulation during preimplantation mouse embryo development
Dev. Biol.
(1991) - et al.
Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH
Regul. Pept.
(1990) - et al.
Corticotropin-releasing hormone and animal models of anxiety: gene–environment interactions
Biol. Psychiatry
(2000) - et al.
A review of central 5-HT receptors and their function
Neuropharmacology
(1999) - et al.
Measuring normal and pathological anxiety-like behaviour in mice: a review
Behav. Brain Res.
(2001) - et al.
Review: Molecular biology of 5-HT receptors
Neuropharmacology
(1994) - et al.
Physiological and behavioural effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat
Psychoneuroendocrinology
(1997) - et al.
Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress
Peptides
(2001) Are different parts of the extended amygdala involved in fear versus anxiety?
Biol. Psychiatry
(1998)